209 related articles for article (PubMed ID: 37683286)
1. New Therapeutic Approaches to Large-Vessel Vasculitis.
Kaymakci MS; Warrington KJ; Kermani TA
Annu Rev Med; 2024 Jan; 75():427-442. PubMed ID: 37683286
[TBL] [Abstract][Full Text] [Related]
2. Comparing treatment options for large vessel vasculitis.
Macaluso F; Marvisi C; Castrignanò P; Pipitone N; Salvarani C
Expert Rev Clin Immunol; 2022 Aug; 18(8):793-805. PubMed ID: 35714219
[TBL] [Abstract][Full Text] [Related]
3. Biological treatments in giant cell arteritis & Takayasu arteritis.
Samson M; Espígol-Frigolé G; Terrades-García N; Prieto-González S; Corbera-Bellalta M; Alba-Rovira R; Hernández-Rodríguez J; Audia S; Bonnotte B; Cid MC
Eur J Intern Med; 2018 Apr; 50():12-19. PubMed ID: 29146018
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
Hellmich B; Águeda AF; Monti S; Luqmani R
Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
[TBL] [Abstract][Full Text] [Related]
5. Management of large-vessel vasculitis.
Salvarani C; Hatemi G
Curr Opin Rheumatol; 2019 Jan; 31(1):25-31. PubMed ID: 30461542
[TBL] [Abstract][Full Text] [Related]
6. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
Maz M; Chung SA; Abril A; Langford CA; Gorelik M; Guyatt G; Archer AM; Conn DL; Full KA; Grayson PC; Ibarra MF; Imundo LF; Kim S; Merkel PA; Rhee RL; Seo P; Stone JH; Sule S; Sundel RP; Vitobaldi OI; Warner A; Byram K; Dua AB; Husainat N; James KE; Kalot MA; Lin YC; Springer JM; Turgunbaev M; Villa-Forte A; Turner AS; Mustafa RA
Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1071-1087. PubMed ID: 34235871
[TBL] [Abstract][Full Text] [Related]
7. [Large Vessel Vasculitides: Giant Cell Arteritis and Takayasu Arteritis - Similarities and Differences].
Gloor AD; Christ L
Ther Umsch; 2022 Jun; 79(5):221-228. PubMed ID: 35583023
[TBL] [Abstract][Full Text] [Related]
8. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
9. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
Boiardi L; Galli E; Macchioni P; Muratore F; Klinowski G; Hunder GG; Casali M; Besutti G; Spaggiari L; Versari A; Croci S; Mancuso P; Rossi PG; Marvisi C; Salvarani C
Semin Arthritis Rheum; 2023 Apr; 59():152173. PubMed ID: 36780709
[TBL] [Abstract][Full Text] [Related]
10. [Long-term complications, monitoring and interventional treatment of large vessel vasculitis].
Wipfler-Freißmuth E; Dejaco C; Both M
Z Rheumatol; 2020 Aug; 79(6):523-531. PubMed ID: 32430565
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the diagnosis and therapy of large vessel vasculitis.
Keser G; Atagunduz P; Soy M
Pol Arch Intern Med; 2022 Jun; 132(6):. PubMed ID: 35699647
[TBL] [Abstract][Full Text] [Related]
12. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
Maz M; Chung SA; Abril A; Langford CA; Gorelik M; Guyatt G; Archer AM; Conn DL; Full KA; Grayson PC; Ibarra MF; Imundo LF; Kim S; Merkel PA; Rhee RL; Seo P; Stone JH; Sule S; Sundel RP; Vitobaldi OI; Warner A; Byram K; Dua AB; Husainat N; James KE; Kalot MA; Lin YC; Springer JM; Turgunbaev M; Villa-Forte A; Turner AS; Mustafa RA
Arthritis Rheumatol; 2021 Aug; 73(8):1349-1365. PubMed ID: 34235884
[TBL] [Abstract][Full Text] [Related]
13. Biologic treatment of large-vessel vasculitides.
Schäfer VS; Zwerina J
Curr Opin Rheumatol; 2012 Jan; 24(1):31-7. PubMed ID: 22089099
[TBL] [Abstract][Full Text] [Related]
14. Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021.
Henes J; Richter JG; Thiele K; Kiltz U; Callhoff J; Albrecht K
Rheumatol Int; 2024 Mar; 44(3):497-507. PubMed ID: 38180499
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
[TBL] [Abstract][Full Text] [Related]
16. Highlights in clinical medicine-Giant cell arteritis, polymyalgia rheumatica and Takayasu's arteritis: pathogenic links and therapeutic implications.
Solimando AG; Vacca A; Dammacco F
Clin Exp Med; 2022 Nov; 22(4):509-518. PubMed ID: 34741677
[TBL] [Abstract][Full Text] [Related]
17. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Hellmich B; Agueda A; Monti S; Buttgereit F; de Boysson H; Brouwer E; Cassie R; Cid MC; Dasgupta B; Dejaco C; Hatemi G; Hollinger N; Mahr A; Mollan SP; Mukhtyar C; Ponte C; Salvarani C; Sivakumar R; Tian X; Tomasson G; Turesson C; Schmidt W; Villiger PM; Watts R; Young C; Luqmani RA
Ann Rheum Dis; 2020 Jan; 79(1):19-30. PubMed ID: 31270110
[TBL] [Abstract][Full Text] [Related]
18. [Giant-cell arteritis and Takayasu arteritis: epidemiological, diagnostic and treatment aspects].
Chaigne-Delalande S; de Menthon M; Lazaro E; Mahr A
Presse Med; 2012 Oct; 41(10):955-65. PubMed ID: 22940467
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostics and treatment of large vessel vasculitis].
Bauer CJ; Schäfer VS
Inn Med (Heidelb); 2024 Feb; 65(2):107-113. PubMed ID: 38240814
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic update in large vessel vasculitides.
Pérez-Esteban S; González-Gay MA; Castañeda S
Rev Clin Esp (Barc); 2013 Oct; 213(7):338-46. PubMed ID: 23683962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]